VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd. has announced an extension and increase of its private placement offerings, aiming to raise up to $3 million through unsecured convertible debentures and $700,000 through non-brokered placements. The funds will be used to support the company’s operational costs, including sales, marketing, and hiring additional personnel, as it continues to lead in AI applications for echocardiography.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
